Skip to content

Clinical trials

Completed Psychotic Disorders trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Status: Completed Country / region: United Kingdom Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20043
20071
20091
20111
20121
20131
20145
20154
20163
20177
20185
20193
20201
20224
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
King's College London11
University of Manchester6
ACADIA Pharmaceuticals Inc.2
Alkermes, Inc.2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Rene Kahn2
University of Cambridge2
Edinburgh Napier University1
Eisai Co., Ltd.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders43
Schizophrenia25
Bipolar Disorder6
Hallucinations4
Depressive Disorder2
Mental Disorders2
Alzheimer Disease1
Autoimmune Diseases1
Body Weight Changes1
Corticobasal Degeneration1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.